VISCHER advises investors in the seed financing in Lunaphore Technologies SA, in Lausanne, a medical device spin-off from EPFL Lausanne. Lunaphore has developed an innovative tissue diagnostics platform, primarily for analysis and classification of tumors. The platform is based on a microfluidic chip technology that allows fine-tuning of such diagnostic assays and increases their speed and accuracy. The VISCHER Team is led by Dr. Matthias Staehelin (Partner) with Moritz Jäggy (Associate), both Corporate.